Pharma CEOs

AZ’s CEO dismisses “fake news” about his imminent departure
AZ’s CEO dismisses “fake news” about his imminent departure
Pharmaforum
AstraZeneca
Pharma CEOs
Pascal Soriot
Flag link:
Pharma Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns
Pharma Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns
Fierce Pharma
Pharma CEOs
Novartis
executive pay
Vas Narasimhan
Flag link:
Leadership In An Age Of Disruption: Q&A With Abbott Chairman And CEO Miles White
Leadership In An Age Of Disruption: Q&A With Abbott Chairman And CEO Miles White
Forbes
Abbott Labs
Miles White
Pharma CEOs
Flag link:
Novartis CEO lauds Trump administration plan to overhaul rebates
Novartis CEO lauds Trump administration plan to overhaul rebates
Yahoo/Reuters
Novartis
Vas Narasimhan
Pharma CEOs
drug pricing
Donald Trump
drug rebates
Flag link:
Gilead executives predict patience—and some deal scouting—from new CEO Daniel O'Day
Gilead executives predict patience—and some deal scouting—from new CEO Daniel O'Day
Fierce Pharma
Gilead Sciences
Daniel O'Day
M&A
Pharma CEOs
Flag link:
As Novartis Eyes Growth in 2019, the Company Will Likely Cut Some Prices
As Novartis Eyes Growth in 2019, the Company Will Likely Cut Some Prices
BioSpace
Novartis
drug pricing
Pharma CEOs
Vas Narasimhan
Flag link:
CEO Emma Walmsley takes GlaxoSmithKline on a quest for identity
CEO Emma Walmsley takes GlaxoSmithKline on a quest for identity
Stat
GSK
Pharma CEOs
Emma Walmsley
Flag link:
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Endpoints
Genentech
Roche
Alexander Hardy
Pharma CEOs
Flag link:
Has Abbott's Acquisitive Miles White Made His Last Big Deal?
Has Abbott's Acquisitive Miles White Made His Last Big Deal?
Forbes
Abbott Labs
Pharma CEOs
Miles White
M&A
Flag link:
Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard
Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard
Forbes
Novartis
Pharma CEOs
Vas Narasimhan
digital pharma
Flag link:
Want to buy Clovis? Step up. ‘Everybody knows where to find me,’ CEO says
Want to buy Clovis? Step up. ‘Everybody knows where to find me,’ CEO says
Fierce Pharma
M&A
Patrick Mahaffy
Pharma CEOs
Clovis Oncology
JPMHC 2019
Flag link:
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
GoinPharma
Teva Pharmaceutical
debt
JPMHC 2019
Kåre Schultz
Pharma CEOs
Flag link:
JPM: Why hasn't Merck been making deals? It's not for lack of trying, CEO says
JPM: Why hasn't Merck been making deals? It's not for lack of trying, CEO says
Fierce Pharma
Merck
Pharma CEOs
Ken Frazier
M&A
JPMHC 2019
Flag link:
3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear
3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear
Motley Fool
Pfizer
Albert Bourla
Pharma CEOs
JPMHC 2019
Flag link:
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises
Fierce Pharma
Novartis
Pharma CEOs
CAR-T
Kymriah
Vas Narasimhan
JPMHC 2019
Flag link:
John Johnson is back trying his hand as a turnaround artist for a troubled biotech. Can he win this time?
John Johnson is back trying his hand as a turnaround artist for a troubled biotech. Can he win this time?
Endpoints
Melinta Therapeutics
John Johnson
Pharma CEOs
Flag link:
New Pfizer CEO's top priorities? Think China and pipeline, not deals: analyst
New Pfizer CEO's top priorities? Think China and pipeline, not deals: analyst
Fierce Pharma
Pfizer
Pharma CEOs
Albert Bourla
Ian Read
China
Flag link:
AbbVie streamlines management team to 4 executives under CEO Gonzalez
AbbVie streamlines management team to 4 executives under CEO Gonzalez
Fierce Pharma
AbbVie
reorganization
Richard Gonzalez
Pharma CEOs
Flag link:
Alnylam CEO talks politics, gene therapy and not becoming Pfizer
Alnylam CEO talks politics, gene therapy and not becoming Pfizer
BioPharma Dive
Alnylam
RNAi
Onpattro
Pharma CEOs
John Maraganore
Flag link:
J&J chief figures Amazon could shake up pharma's distribution, rebates and more
J&J chief figures Amazon could shake up pharma's distribution, rebates and more
Fierce Pharma
Amazon
JNJ
Pharma CEOs
Alex Gorsky
distribution
drug rebates
Flag link:

Pages